Adverse Outcome Pathway on Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF

Interference with endogenous developmental processes that are regulated by the aryl hydrocarbon receptor (AHR), through sustained exogenous activation, causes molecular, structural, and functional cardiac abnormalities in avian, mammalian and piscine embryos; this cardiotoxicity ultimately leads to...

Full description

Bibliographic Details
Main Author: Farhat, Amani
Other Authors: Kennedy, Sean W.
Format: eBook
Language:English
Published: Paris OECD Publishing 2019
Series:OECD Series on Adverse Outcome Pathways
Subjects:
Online Access:
Collection: OECD Books and Papers - Collection details see MPG.ReNa
LEADER 02030nma a2200277 u 4500
001 EB002076323
003 EBX01000000000000001216413
005 00000000000000.0
007 cr|||||||||||||||||||||
008 220928 ||| eng
100 1 |a Farhat, Amani 
245 0 0 |a Adverse Outcome Pathway on Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF  |h Elektronische Ressource  |c Amani, Farhat and Sean W., Kennedy 
260 |a Paris  |b OECD Publishing  |c 2019 
300 |a 104 p 
653 |a Social Issues/Migration/Health 
653 |a Environment 
700 1 |a Kennedy, Sean W. 
041 0 7 |a eng  |2 ISO 639-2 
989 |b OECD  |a OECD Books and Papers 
490 0 |a OECD Series on Adverse Outcome Pathways 
024 8 |a /10.1787/063e1bf4-en 
856 4 0 |a oecd-ilibrary.org  |u https://doi.org/10.1787/063e1bf4-en  |x Verlag  |3 Volltext 
082 0 |a 363 
082 0 |a 304 
082 0 |a 610 
520 |a Interference with endogenous developmental processes that are regulated by the aryl hydrocarbon receptor (AHR), through sustained exogenous activation, causes molecular, structural, and functional cardiac abnormalities in avian, mammalian and piscine embryos; this cardiotoxicity ultimately leads to severe oedema and embryo death in birds and fish and some strains of rat. There have been numerous proposed mechanisms of action for this toxicity profile, many of which include the dysregulation of vascular endothelial growth factor (VEGF). This AOP describes the indirect suppression of VEGF expression through the sequestration of the aryl hydrocarbon receptor nuclear translocator (ARNT) by AHR. ARNT is common dimerization partner for both AHR and hypoxia inducible factor alpha (HIF-1α), which stimulates angiogenesis through the transcriptional regulation of VEGF. The suppression of VEGF thereby reduces cardiomyocyte and endothelial cell proliferation, altering cardiovascular morphology and reducing cardiac output, which ultimately leads to congestive heart failure and death